NuGene Growing Its Stem-Cell Cosmeceuticals Biz; Regulatory Risks Noted
This article was originally published in The Rose Sheet
Executive Summary
NuGene's sales have soared with expanded distribution, but increased regulation continues to be a risk to its human stem-cell-based cosmeceuticals business, the firm notes. Skin and hair-care line extensions will launch later this year, and the company is considering developing an in-house sales force.
You may also be interested in...
AIVITA Stem Cell Skin Care; Scent Republik Fragrance Stiks For Tweens; More Cosmetics Product News
AIVITA Biomedical plans to support its clinical cancer development programs with revenue from a skin-care line featuring its proprietary stem cell technology; Scent Republik, founded by two dads as a fresh take on kid's cosmetics, launches fragrance "stiks." More news in brief.
FDA Shows Skin Authority Who’s Boss With Warning For Drug Claims
Yet another skin-care marketer, Skin Authority, has been served with an FDA warning letter for excessive product claims that identify its offerings as drugs. The agency cites statements touting the firm’s ingredient benefits, including collagen production, improved circulation, inflammation relief and hyperpigmentation treatment, consistent with other warnings issued to cosmetics firms in recent months.
Stem-Cell Cosmeceutical Firm NuGene Eyes Skin-Care Drug Approvals
Acne treatments and burn-relief products based on human stem-cell media may be forthcoming from NuGene International, as newly created subsidiary NuGene BioPharma looks to parlay the firm’s existing technology into skin-care pharmaceuticals subject to FDA approval.